268P Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i) in three institutions
- Resource Type
- Source
- Annals of Oncology. 33:S660
- Subject
Oncology Hematology - Language
- ISSN
- 0923-7534